FBTCX
Price
$18.37
Change
+$0.29 (+1.60%)
Updated
Apr 17 closing price
Net Assets
1.39B
JFNIX
Price
$64.83
Change
+$0.02 (+0.03%)
Updated
Apr 17 closing price
Net Assets
4.71B
Ad is loading...

FBTCX vs JFNIX

Header iconFBTCX vs JFNIX Comparison
Open Charts FBTCX vs JFNIXBanner chart's image
Fidelity Advisor Biotechnology C
Price$18.37
Change+$0.29 (+1.60%)
VolumeN/A
Net Assets1.39B
Janus Henderson Global Life Sciences I
Price$64.83
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets4.71B
FBTCX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTCX vs. JFNIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTCX is a Buy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.71B vs. FBTCX (1.39B). FBTCX pays higher dividends than JFNIX: FBTCX (2.90) vs JFNIX (0.39). FBTCX was incepted earlier than JFNIX: FBTCX (24 years) vs JFNIX (16 years). FBTCX (1.71) is less costly to investors than JFNIX (0.77). FBTCX is a more actively managed with annual turnover of: 73.00 vs. JFNIX (35.00). FBTCX has a lower initial minimum investment than JFNIX: FBTCX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -7.78 vs. FBTCX (-16.13). JFNIX return over 5 years is better than : 12.94 vs. FBTCX (-21.40).
FBTCXJFNIXFBTCX / JFNIX
Total Expense Ratio1.710.77222%
Annual Report Gross Expense Ratio1.710.77222%
Fund Existence24 years16 years-
Gain YTD-14.191-4.690303%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B4.71B30%
Annual Yield % from dividends2.900.39736%
Returns for 1 year-16.13-7.78207%
Returns for 3 years-2.07-0.70297%
Returns for 5 years-21.4012.94-165%
Returns for 10 years-28.499.62-296%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLSSX11.580.13
+1.14%
Selected International S
ODVNX35.75N/A
N/A
Invesco Developing Markets R
PEOPX51.81N/A
N/A
BNY Mellon S&P 500 Index
SMVIX18.50N/A
N/A
SEI Small Cap Value I (SIMT)
ESERX33.41N/A
N/A
Eaton Vance Atlanta Capital Sel Eq R6